Citation: Yukun Li, Tianhao Mao, Liwei Zheng, Zhao Zhou, Qianqian Jiang, Xinyu Du, Ziyuan Ma, Xin Liu, Ting Zhang, Guochao Wei, Lin Wang, Yongzhen Liu, Xiaojing Zhang, Shourong Liu, Xiangmei Chen, Fengmin Lu. Host factor RBM25 promotes HBV replication through Yin Yang 1-mediated cccDNA transcription .VIROLOGICA SINICA, 2025, 40(3) : 374-387.  http://dx.doi.org/10.1016/j.virs.2025.05.004

Host factor RBM25 promotes HBV replication through Yin Yang 1-mediated cccDNA transcription

  • The persistence of covalently closed circular DNA (cccDNA) in hepatitis B virus (HBV)-infected hepatocytes remains a major obstacle to effective antiviral treatment. Understanding the molecular mechanisms regulating HBV cccDNA transcription is essential for developing novel therapeutic strategies. In this study, we investigated the role of RNA binding motif protein 25 (RBM25) in HBV replication, focusing on its interaction with cccDNA and its regulation of host transcription factors. The results demonstrated that RBM25 knockdown markedly inhibited HBV replication, reducing levels of HBV DNA, hepatitis B e antigen (HBeAg), hepatitis B surface antigen (HBsAg), HBV RNA, and L-HBs in HBV-replicating and infected cell models. Consistent results were observed in a mouse model hydrodynamically injected with 1.2 × HBV plasmid. Conversely, RBM25 overexpression significantly enhanced HBV replication. Mechanistically, RBM25 promoted HBV promoter activities by binding to cccDNA through its RE/RD and PWI domains. This effect was mediated by increased Yin Yang 1 (YY1) expression, which enhanced acetylation of cccDNA-bound histones, promoting HBV transcription. Furthermore, RBM25 expression was upregulated and translocated to the nucleus following core protein expression and accumulation, while overexpression of RBM25 promoted core protein degradation. In conclusion, this study demonstrates that RBM25 is a novel host factor that enhances HBV replication by upregulating YY1-dependent transcriptional activation of cccDNA. It also reveales a reciprocal regulatory mechanism between the HBV core protein and RBM25, which helps sustain HBV replication.

  • 加载中
  • 10.1016j.virs.2025.05.004-ESM.docx
    1. Belloni, L., Pollicino, T., De Nicola, F., Guerrieri, F., Raffa, G., Fanciulli, M., Raimondo, G., Levrero, M., 2009. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. PNAS. 106, 19975-19979.

    2. Carlson, S.M., Soulette, C.M., Yang, Z., Elias, J.E., Brooks, A.N., Gozani, O., 2017. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation. J Biol Chem. 292, 13381-13390.

    3. Dandri, M., 2020. Epigenetic modulation in chronic hepatitis B virus infection. Semin Immunopathol. 42, 173-185.

    4. Fortes, P., Longman, D., McCracken, S., Ip, J. Y., Poot, R., Mattaj, I. W., Cáceres, J. F., Blencowe, B. J., 2007. Identification and characterization of RED120: a conserved PWI domain protein with links to splicing and 3’-end formation. FEBS letters 581, 3087-3097.

    5. Gao, W., Jia, Z., Tian, Y., Yang, P., Sun, H., Wang, C., Ding, Y., Zhang, M., Zhang, Y., Yang, D., Tian, Z., Zhou, J., Ruan, Z., Wu, Y., Ni, B., 2020. HBx protein contributes to liver carcinogenesis by H3K4me3 modification through stabilizing WD repeat domain 5 protein. Hepatology. 71, 1678-1695.

    6. Gong, D., Yang, F., Li, F., Qian, D., Wu, M, Shao, Z., Wu, Mian, Wu, J., Shi, Y., 2013. Crystal structure and functional characterization of the human RBM25 PWI domain and its flanking basic region. Biochem J. 450, 85-94.

    7. Gu, Z., Jiang, Q., Abulaiti, A., Chen, Xiaojie, Li, M., Gao, N., Guan, G., Zhang, T., Yang, D., Xi, J., Yu, G., Liu, S., Zhu, Z., Gao, Z., Zhao, J., Huang, H., Chen, Xiangmei, Lu, F., 2024. Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretion. JHEP Rep. 6, 101144.

    8. Hensel, K.O., Rendon, J.C., Navas, M.C., Rots, M.G., Postberg, J., 2017. Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies. FEBS J. 284, 3550-3572.

    9. Hsu, Y.C., Huang, D.Q., Nguyen, M.H., 2023. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 20, 524-537.

    10. Kanno, T., Lin, W.D., Fu, J.L., Chang, C.L., Matzke, A.J.M., Matzke, M., 2017. A genetic screen for pre-mRNA splicing mutants of Arabidopsis thaliana identifies putative U1 snRNP components RBM25 and PRP39a. Genetics. 208, 1347-1359.

    11. Ladner, S.K., Otto, M.J., Barker, C.S., Zaifert, K., Wang, G.H., Guo, J.T., Seeger, C., King, R.W., 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. 41, 1715-1720.

    12. Makokha, G.N., Abe-Chayama, H., Chowdhury, S., Hayes, C.N., Tsuge, M., Yoshima, T., Ishida, Y., Zhang, Y., Uchida, T., Tateno, C., Akiyama, R., Chayama, K., 2019. Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP. Sci Rep. 9, 8462.

    13. Michailidis, E., Pabon, J., Xiang, K., Park, P., Ramanan, V., Hoffmann, H.H., Schneider, W.M., Bhatia, S.N., De Jong, Y.P., Shlomai, A., Rice, C.M., 2017. A robust cell culture system supporting the complete life cycle of hepatitis B virus. Sci Rep. 7, 16616.

    14. Miyakawa, K., Nishi, M., Ogawa, M., Matsunaga, S., Sugiyama, M., Nishitsuji, H., Kimura, H., Ohnishi, M., Watashi, K., Shimotohno, K., Wakita, T., Ryo, A., 2022. Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins. Nat Commun. 13, 531.

    15. Montanari, N.R., Ramirez, R., Aggarwal, A., Buuren, N., Doukas, M., Moon, C., Turner, S., Diehl, L., Li, L., Debes, J.D., Feierbach, B., Boonstra, A., 2022. Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection. J Hepatol. 77, 332-343.

    16. Pollicino, T., Belloni, L., Raffa, G., Pediconi, N., Squadrito, G., Raimondo, G., Levrero, M., 2006. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology. 130, 823-837.

    17. Qi, Z., Li, G., Hu, H., Yang, C., Zhang, X., Leng, Q., Xie, Y., Yu, D., Zhang, X., Gao, Y., Lan, K., Deng, Q., 2014. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice. J Virol. 88, 8045-8056.

    18. Qian, G., Jin, F., Chang, L., Yang, Y., Peng, H., Duan, C., 2012. NIRF, a novel ubiquitin ligase, interacts with hepatitis B virus core protein and promotes its degradation. Biotechnol Lett. 34, 29-36.

    19. Ren, F., Ren, J.H., Song, C.L., Tan, M., Yu, H.B., Zhou, Y.J., Qin, Y.P., Cheng, S.T., Zhang, Y., Huang, A.L., Chen, J., Yang, X., 2020. LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor. Clin Sci. 134, 3007-3022.

    20. Senechal, R. Le, Keruzore, M., Quillevere, A., Loaec, N., Dinh, V.T., Reznichenko, O., Guixens-Gallardo, P., Corcos, L., Teulade-Fichou, M.P., Granzhan, A., Blondel, M., 2023. Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA. Nucleic Acids Res. 51, 11239-11257.

    21. Sheena, B.S., Hiebert, L., Han, H., Ippolito, H., 2022. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 7, 796-829.

    22. Shen, C., Feng, X., Mao, T., Yang, D., Zou, J., Zao, X., Deng, Q., Chen, X., Lu, F., 2020. Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11. Emerg Microbes Infect. 9, 2455-2464.

    23. Sozzi, V., McCoullough, L., Mason, H., Littlejohn, M., Revill, P.A., 2022. The in vitro replication phenotype of hepatitis B virus (HBV) splice variant Sp1. Virology. 574, 65-70.

    24. Sun, S., Nakashima, K., Ito, M., Li, Y., Chida, T., Takahashi, H., Watashi, K., Sawasaki, T., Wakita, T., Suzuki, T., 2017. Involvement of PUF60 in transcriptional and post-transcriptional regulation of hepatitis B virus pregenomic RNA expression. Sci Rep. 7, 12874.

    25. Sun, Y., Teng, Y., Wang, L., Zhang, Z., Chen, C.J., Wang, Y., Zhang, X., Xiang, P., Song, X., Lu, J., Li, N., Gao, L., Liang, X., Xia, Y., Wu, Z., Ma, C., 2022. LINC01431 promotes histone H4R3 methylation to impede HBV covalently closed circular DNA transcription by stabilizing PRMT1. Adv Sci. 9, 2103135.

    26. Szymczyna, B.R., Bowman, J., McCracken, S., Pineda-Lucena, A., Lu, Y., Cox, B., Lambermon, M., Graveley, B.R., Arrowsmith, C.H., Blencowe, B.J., 2003. Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-MRNA processing. Genes Dev. 17, 461-475.

    27. Tan, M., Liu, Y., Dong, M., Cheng, S., Ren, J., Zhang, H., Chen, W., Li, D., Gao, T., Chen, J., Zhang, Z., 2024. Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3. Antiviral Res. 221, 105796.

    28. Teng, Y., Xu, Z., Zhao, K., Zhong, Y., Wang, J., Zhao, L., Zheng, Z., Hou, W., Zhu, C., Chen, X., Protzer, U., Li, Y., Xia, Y., 2021. Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection. J Hepatol. 75, 1072-1082.

    29. Tropberger, P., Mercier, A., Robinson, M., Zhong, W., Ganem, D.E., Holdorf, M., 2015. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. PNAS. 112(42): 5715-5724.

    30. Tsukuda, S., Watashi, K., 2020. Hepatitis B virus biology and life cycle. Antiviral Res. 182, 104925.

    31. Turton, K.L., Meier-Stephenson, V., Badmalia, M.D., Coffin, C.S., Patel, T.R., 2020. Host transcription factors in hepatitis B virus RNA synthesis. Viruses. 12, 160.

    32. Wan, Q., Anugwom, C., Desalegn, H., Debes, J.D., 2022. Hepatocellular carcinoma in hepatitis B and human immunodeficiency virus coinfection in Africa: a focus on surveillance. Hepatoma Res. 8, 39.

    33. Wang, J., Shen, T., Huang, X., Kumar, G.R., Chen, X., Zeng, Z., Zhang, R., Chen, R., Li, T., Zhang, T., Yuan, Q., Li, P.C., Huang, Q., Colonno, R., Jia, J., Hou, J., McCrae, M.A., Gao, Z., Ren, H., Xia, N., Zhuang, H., Lu, F., 2016. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J Hepatol. 65, 700-710.

    34. Wang, J., Li, J., Wu, J., Dong, M., Shen, Z., Lin, Y., Li, F., Zhang, Y., Mao, R., Lu, M., Zhang, J., 2019. Host Gene SEL1L Involved in endoplasmic reticulum-associated degradation pathway could inhibit hepatitis B virus at RNA, DNA, and protein levels. Front Microbiol. 10, 2869.

    35. Wang, W., Qiao, S., Li, G., Cheng, J., Yang, C., Zhong, C., Stovall, D.B., Shi, J., Teng, C., Li, D., Sui, G., 2022. A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters. Nucleic Acids Res. 50, 4917-4937.

    36. Wang, D., Yang, Y., Cao, Y., Meng, M., Wang, X., Zhang, Z., Fu, W., Duan, S., Tang, L., 2023. Histone deacetylase inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1. Sci Rep. 13, 12069.

    37. Wei, L., Ploss, A., 2021. Hepatitis B virus cccDNA is formed through distinct repair processes of each strand. Nat Commun. 12, 1591.

    38. Wu, Y., Chen, H, Chen, Y., Qu, L., Zhang, E., Wang, Z., Wu, Y., Yang, R., Mao, R., Lu, C., Fan, Y., 2019. HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif. Aging. 11, 2430-2446.

    39. Xiao, R., Chen, J.Y., Liang, Z., Luo, D., Chen, G., Lu, Z.J., Chen, Y., Zhou, B., Li, H., Du, X., Yang, Y., San, M., Wei, X., Liu, W., Lecuyer, E., Graveley, B.R., Yeo, G.W., Burge, C.B., Zhang, M.Q., Zhou, Y., Fu, X.D., 2019. Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription. Cell. 178, 107-121.

    40. Yan, Z., Zeng, J., Yu, Y., Xiang, K., Hu, H., Zhou, X., Gu, L., Wang, L., Zhao, J., Young, J.A.T., Gao, L., 2017. HBVcircle: a novel tool to investigate hepatitis B virus covalently closed circular DNA. J Hepatol. 66, 1149-1157.

    41. Yang, G., Feng, J., Liu, Y., Zhao, M., Yuan, Y., Yuan, H., Yun, H., Sun, M., Bu, Y., Liu, L., Liu, Z., Niu, J.Q., Yin, M., Song, X., Miao, Z., Lin, Z., Zhang, X., 2019. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome. Theranostics. 9, 7345-7358.

    42. Yang, Z., Qu, C.B., Zhang, Y., Zhang, W.F., Wang, D.D., Gao, C.C., Ma, L., Chen, J.S., Liu, K.L., Zheng, B., Zhang, X.H., Zhang, M.L., Wang, X.L., Wen, J.K., Li, W., 2019. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene. 38, 2516-2532.

    43. Yao, Y., Yang, B., Chen, Y., Wang, H., Hu, X., Zhou, Y., Gao, X., Lu, M., Niu, J., Wen, Z., Wu, C., Chen, X., 2019. RNA-binding motif protein 24 (RBM24) is involved in pregenomic RNA packaging by mediating interaction between hepatitis B virus polymerase and the epsilon element. J Virol. 93, 2161.

    44. Zhang, Y.F., Wang, Y.X., Zhang, N., Lin, Z.H., Wang, L.R., Feng, Y., Pan, Q., Wang, L., 2021. Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma. Bioengineered. 12, 1202-1211.

    45. Zhong, Y., Wu, C., Xu, Z., Teng, Y., Zhao, L., Zhao, K., Wang, J., Wang, W., Zhan, Q., Zhu, C., Chen, X., Liang, K., Cheng, X., Xia, Y., 2022. Hepatitis B virus core protein is not required for covalently closed circular DNA transcriptional regulation. J Virol. 96, 136222.

    46. Zhou, A., Ou, A.C., Cho, A., Benz, E.J., Huang, S.C., 2008. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5’ splice site selection. Mol Cell Biol. 28, 5924-5936.

    47. Zhou, J., Hua, Y., Liu, Y., Wu, T., Xu, H., Wang, Z., Wang, X., Niu, J., 2024. A mutual regulatory loop between transcription factor Yin Yang 1 and hepatitis B virus replication influences chronic hepatitis B. Antiviral Res. 226, 105889.

    48. Zlotnick, A., Venkatakrishnan, B., Tan, Z., Lewellyn, E., Turner, W., Francis, S., 2015. Core protein: a pleiotropic keystone in the HBV lifecycle. Antiviral Res. 121, 82-93.

  • 加载中

Figures(1)

Article Metrics

Article views(6590) PDF downloads(13) Cited by()

Related
Proportional views

    Host factor RBM25 promotes HBV replication through Yin Yang 1-mediated cccDNA transcription

      Corresponding author: Xiangmei Chen, xm_chen6176@bjmu.edu.cn
      Corresponding author: Fengmin Lu, lu.fengmin@hsc.pku.edu.cn
    • a. Department of Microbiology & Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, 100191, China;
    • b. Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, 100044, China;
    • c. Precision Medicine Center, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, 450052, China;
    • d. School of Medical Sciences, University of Sydney, Sydney, NSW, 2050, Australia;
    • e. Model Animal Research Center, Medical School of Nanjing University, Nanjing, 210061, China;
    • f. Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou Xixi Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, 310023, China

    Abstract: The persistence of covalently closed circular DNA (cccDNA) in hepatitis B virus (HBV)-infected hepatocytes remains a major obstacle to effective antiviral treatment. Understanding the molecular mechanisms regulating HBV cccDNA transcription is essential for developing novel therapeutic strategies. In this study, we investigated the role of RNA binding motif protein 25 (RBM25) in HBV replication, focusing on its interaction with cccDNA and its regulation of host transcription factors. The results demonstrated that RBM25 knockdown markedly inhibited HBV replication, reducing levels of HBV DNA, hepatitis B e antigen (HBeAg), hepatitis B surface antigen (HBsAg), HBV RNA, and L-HBs in HBV-replicating and infected cell models. Consistent results were observed in a mouse model hydrodynamically injected with 1.2 × HBV plasmid. Conversely, RBM25 overexpression significantly enhanced HBV replication. Mechanistically, RBM25 promoted HBV promoter activities by binding to cccDNA through its RE/RD and PWI domains. This effect was mediated by increased Yin Yang 1 (YY1) expression, which enhanced acetylation of cccDNA-bound histones, promoting HBV transcription. Furthermore, RBM25 expression was upregulated and translocated to the nucleus following core protein expression and accumulation, while overexpression of RBM25 promoted core protein degradation. In conclusion, this study demonstrates that RBM25 is a novel host factor that enhances HBV replication by upregulating YY1-dependent transcriptional activation of cccDNA. It also reveales a reciprocal regulatory mechanism between the HBV core protein and RBM25, which helps sustain HBV replication.

    Figure (1)  Reference (48) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return